<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html lang="en" xml:lang="en" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">


<meta name="wpd_version" content="0.2">
<meta name="wpd_baseurl" content="http://www.nature.com/jp/journal/v27/n5/full/7211686a.html">
<meta name="wpd_url" content="http://www.nature.com/jp/journal/v27/n5/full/7211686a.html">
<meta name="wpd_date" content="2016-06-21T14:26Z">
<script src="linkid.js" async="" type="text/javascript"></script><script src="beacon.js"></script><script src="injection_settings" async=""></script><script src="article_status" async=""></script><script src="info" async=""></script><script src="gpt.js" async="" type="text/javascript"></script><script src="e2T.js" async="" type="text/javascript"></script><script src="moatcontent.js" async="" type="text/javascript"></script><script src="analytics.js"></script><script src="wtid.js" async="" type="text/javascript"></script><script src="268f93c7ffaea689dd05656a0e3a7582.js"></script><script src="db4193efe5be1708708027efbb147908.js"></script><script src="845e63cc4e4705a7fa4d6ce3da766db6.js"></script><script src="5bf2c1282ac6027d682e358e449077d4.js"></script><script src="32036dba87d51c9d47889b37b8d5aa65.js"></script><script src="b8a2ae73c6a580f7f66e15f3faefe546.js"></script><script src="56278744e1862cc31b1185139bf52721.js"></script><script src="8e288bb5499b7364a5a71defe67c3f12.js"></script><script src="67b5bb1bbfd64f811e99b2a29b8b5bdf.js" async="" type="text/javascript"></script><script src="controltag.js.726d287890a4d2c520d4a7a450e210ea" async=""></script><script src="serverComponent.php"></script>
<!-- super head top -->

<title>Journal of Perinatology - Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease</title><!--Journal of Perinatology--><!-- metadata and links -->

	<meta name="robots" content="noarchive">
	
	                
	
		




































        
               
      









        
                


 





									





	
				
  




	
				
         
        
  

 

 


 


 


 
 
  
 
 <meta name="robots" content="noarchive">





<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="robots" content="noarchive">

<link rel="shortcut icon" href="favicon.ico">

<link rel="home" href="http://www.nature.com/jp/" title="home">
<link rel="help" title="help" href="http://www.nature.com/help/">

<link href="http://www.nature.com/jp/current_issue/rss/index.html" type="application/rss+xml" rel="alternate" title="Journal of Perinatology current issue RSS feed">
<link rel="search" type="application/opensearchdescription+xml" href="http://www.nature.com/opensearch/opensearch.xml" title="nature.com">
<link rel="search" type="application/sru+xml" href="http://www.nature.com/opensearch/request" title="nature.com">


			
					<script src="controltag" async="" type="text/javascript"></script><script type="text/javascript" src="Bootstrap.js"></script><script class="kxct" data-id="Jn7TaPwq" data-timing="async" data-version="1.9" type="text/javascript">window.Krux||((Krux=function(){Krux.q.push(arguments)}).q=[]);(function(){var k=document.createElement("script");k.type="text/javascript";k.async=true;var m,src=(m=location.href.match(/\bkxsrc=([^&]+)/))&&decodeURIComponent(m[1]);k.src = /^https?:\/\/([a-z0-9_\-\.]+\.)?krxd\.net(:\d{1,5})?\//i.test(src) ? src : src === "disable" ? "" :(location.protocol==="https:"?"https:":"http:")+"//cdn.krxd.net/controltag?confid=Jn7TaPwq";var s=document.getElementsByTagName("script")[0];s.parentNode.insertBefore(k,s);}());</script><script class="kxint" type="text/javascript">window.Krux || ((Krux = function() {Krux.q.push(arguments);}).q = []);(function() {function retrieve(n) {var m, k = 'kx' + n;if (window.localStorage) {return window.localStorage[k] || '';} else if (navigator.cookieEnabled) {m = document.cookie.match(k + '=([^;]*)');return (m && unescape(m[1])) || '';} else {return '';}}Krux.user = retrieve('user');Krux.segments = retrieve('segs') ? retrieve('segs').split(',') : []; var dfpp = [];if (Krux.user) {dfpp.push('kuid=' + Krux.user);}for (var i = 0; i < Krux.segments.length; i++) {dfpp.push('ksg=' + Krux.segments[i]);}Krux.dfppKeyValues = dfpp.length ? dfpp.join(';') + ';' : '';})();</script>
		
			
<meta name="keywords" content="JPER, neonatology, perinatology, maternal-fetal, premature, neonate, perinatal, preterm, gestational age, congenital">
<meta name="description" content="JPER is a multi-disciplinary journal that promotes the health of the preterm infant.">

<!-- end metadata and links -->
<!-- style -->

																																											
		
		    
		    
		    
		    
		    
		    
		    
		    
	



<script type="text/javascript"><!--//--><![CDATA[//><!--
	(function() {
		var elements = [];
					elements.push('.nojava');
				var c = elements.join(', ') + ' { display: none; } ';
		var s = document.createElement('style');
		s.type = 'text/css';
		if (s.styleSheet) {
			s.styleSheet.cssText = c;
		} else {
			s.appendChild(document.createTextNode(c));
		}

		(function() {
			var head = document.getElementsByTagName('head');
			if (head && head[0]) {
				head[0].appendChild(s);
			} else {
				setTimeout(arguments.callee, 10);
			}
		})();
	})();
//--><!]]></script>









																																																																																																												
																					
																																																																																																												
																									<!--[if IE 8]>
																<link rel="stylesheet" type="text/css" href="/common/style/ie-specific/ie-8.css" />
								<![endif]-->
	
																																																																																						<!--[if lte IE 7]>
														<link rel="stylesheet" type="text/css" href="/common/includes/header/03/style/ie-specific/lte-ie-7.css" />
					<link rel="stylesheet" type="text/css" href="/common/style/ie-specific/lte-ie-7.css" />
					<link rel="stylesheet" type="text/css" href="/aj/style/ie-specific/lte-ie-7.css" />
						<![endif]-->
																																							
																													<!--[if IE 7]>
																<link rel="stylesheet" type="text/css" href="/common/includes/header/03/style/ie-specific/ie-7.css" />
					<link rel="stylesheet" type="text/css" href="/common/style/ie-specific/ie-7.css" />
					<link rel="stylesheet" type="text/css" href="/aj/style/ie-specific/ie-7.css" />
								<![endif]-->
	
																																																																																																												
																																	<!--[if IE 6]>
							<script type="text/javascript" src="/common/scripts/ie-specific/ie-6.js"></script>
																<link rel="stylesheet" type="text/css" href="/common/includes/header/03/style/ie-specific/ie-6.css" />
					<link rel="stylesheet" type="text/css" href="/common/includes/footer/03/style/ie-specific/ie-6.css" />
					<link rel="stylesheet" type="text/css" href="/common/style/ie-specific/ie-6.css" />
					<link rel="stylesheet" type="text/css" href="/aj/style/ie-specific/ie-6.css" />
					<link rel="stylesheet" type="text/css" href="/jp/style/ie-specific/ie-6.css" />
								<![endif]-->
	
 
<!-- end style -->
<!-- super head bottom -->
	<!-- resource metadata -->
			
				 																							
			
				
															
		
			<link title="schema(PRISM)" rel="schema.prism" href="http://prismstandard.org/namespaces/1.2/basic/">
																																																																		<meta name="prism.copyright" content="© 2007 Nature Publishing Group">
					<meta name="prism.rightsAgent" content="permissions@nature.com">
					<meta name="prism.publicationDate" content="2007-03-08">
					<meta name="prism.volume" content="27">
					<meta name="prism.number" content="5">
					<meta name="prism.section" content="Original Article">
					<meta name="prism.startingPage" content="284">
					<meta name="prism.endingPage" content="290">
					<meta name="prism.publicationName" content="Journal of Perinatology">
					<meta name="prism.issn" content="0743-8346">
					<meta name="prism.eIssn" content="1476-5543">
				
			<link title="schema(DC)" rel="schema.dc" href="http://purl.org/dc/elements/1.1/">
																																																																							<meta name="dc.publisher" content="Nature Publishing Group">
					<meta name="dc.language" content="en">
					<meta name="dc.rights" content="© 2007 Nature Publishing Group">
					<meta name="dc.title" content="Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease">
					<meta name="dc.creator" content="R D Christensen">
					<meta name="dc.creator" content="E Henry">
					<meta name="dc.creator" content="S E Wiedmeier">
					<meta name="dc.creator" content="J Burnett">
					<meta name="dc.creator" content="D K Lambert">
					<meta name="dc.identifier" content="doi:10.1038/sj.jp.7211686">
					<meta name="dc.date" content="2007-03-08">
					<meta name="dc.source" content="Journal of Perinatology, Published online: 08 March 2007; | doi:10.1038/sj.jp.7211686">
				
																																																																																							<meta name="citation_fulltext_world_readable" content="">
					<meta name="citation_publisher" content="Nature Publishing Group">
					<meta name="citation_author" content="R D Christensen">
					<meta name="citation_author" content="E Henry">
					<meta name="citation_author" content="S E Wiedmeier">
					<meta name="citation_author" content="J Burnett">
					<meta name="citation_author" content="D K Lambert">
					<meta name="citation_title" content="Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease">
					<meta name="citation_date" content="2007-05-01">
					<meta name="citation_online_date" content="2007-03-08">
					<meta name="citation_volume" content="27">
					<meta name="citation_issue" content="5">
					<meta name="citation_firstpage" content="284">
					<meta name="citation_doi" content="doi:10.1038/sj.jp.7211686">
					<meta name="citation_journal_title" content="Journal of Perinatology">
																																																						<meta name="DCS.dcssip" content="www.nature.com">
					<meta name="WT.tz" content="America/New_York">
					<meta name="Access" content="Yes">
					<meta name="WT.cg_n" content="Journal of Perinatology">
					<meta name="WT.cg_s" content="Original Article">
					<meta name="WT.i_dcsvid" content="">
					<meta name="WT.ec_id" content="">
				
	<meta name="emanating" content="73X43X120X204">



		

		

				<script src="nature_inject-e9d840ff443256d6ce5e43f738d2152a.js" type="text/javascript" async=""></script><script async="" src="pubads_impl_91.js"></script>
<link rel="stylesheet" type="text/css" href="7211686a.css" media="all">
</head>
<body class="www-nature-com-jp js-enabled" id="article">
<!-- super body top -->
	
	<div id="header">
	<!-- global links -->


																		



				</div><!-- /#header -->
		<div id="constrain"><div class="constrain">

<div id="hdr">
			<div class="publications-search" id="top">
			<div class="publications">
				<ul>
														<li class="first jumplink"><a href="#content">Jump&nbsp;to&nbsp;main&nbsp;content</a></li>
										<li class="jumplink"><a href="#journalnav">Jump&nbsp;to&nbsp;navigation</a></li>
																		<li class="nature-link"><a href="http://www.nature.com/">nature.com<span class="hidden"> homepage</span></a></li>
																	<li class="pub1"><a href="http://www.nature.com/siteindex/">Publications&nbsp;A-Z&nbsp;index</a></li><li><a href="http://www.nature.com/browse/">Browse&nbsp;by&nbsp;subject</a></li>								
																																																																																																																	</ul>
			</div>	
		</div>
	
	<span class="cleardiv"><!-- --></span>

			<div class="leaderboard-links">
																																														<div class="user-services">
																					<ul class="list">
																						<li class="us-link li1"><a href="http://www.nature.com/myaccount/">My account</a></li><li class="us-link li2"><a href="http://www.mts-jper.nature.com/" title="Submit  manuscript">Submit manuscript</a></li>															<li class="us-link li3"><a href="http://www.nature.com/register/" title="Register with Nature.com">Register</a></li><li class="us-link li4"><a href="http://www.nature.com/jp/subscribe.html" title="Subscribe to Journal of Perinatology">Subscribe</a></li>													</ul>
																<span class="cleardiv"><!-- --></span>
								</div>
						
							<!-- leaderboard ad -->
				<div class="leaderboard">
										<div class="padder">
																								

							<!-- Using GPT ads -->
																







<script type="text/javascript"><!--//--><![CDATA[//><!--
	var include = '';

	var wp = '';
	if (wp != '') include += 'wp='+wp;
	include += ';';

	var rf = '';
	if (rf != '') include += "rf="+rf;
	include += ';';

	var sp = '';
	if (sp != '') include += "sp="+sp;
	include += ";";

	var ps = '';
	if (ps != '') include += "ps="+ps;
	include += ";";

	var adinf = "lg=no;";

	if(include != ";;;;")
	{
		adinf = include;
	}

	var time = new Date();
	ordval= (time.getTime());

		ord=Math.random()*10000000000000000;
//--><!]]></script>
 
																																																																																																																								
						
																																																		<div class="adunit-leaderboard"> 
							<!-- FLEXI -->
			
			
						
			
		
							
		
													
		
										
		
													
		
										
		
													
		
										
		
													
		
										
		
													
		
										
		
									
		
	
	
		
										
					
		
										
					
		
										
					
		
										
					
		
										
					
		
										
									<div id="div-gpt-ad-1" class="div-gpt-ad adunit-leaderboard" data-gpt-unitpath="/285/jp.nature.com" data-gpt-sizes="728x90" data-gpt-targeting="type=oa;artid=7211686a;issue=5;pos=top;sz=728x90;tile=1">
				<noscript>

					<a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/jp.nature.com&amp;sz=728x90&amp;t=type=oa;artid=7211686a;issue=5;pos=top;sz=728x90;tile=1&amp;c=2654969264472714">
						<img src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/jp.nature.com&amp;sz=728x90&amp;t=type=oa;artid=7211686a;issue=5;pos=top;sz=728x90;tile=1&amp;c=2654969264472714" alt="Advertisement" /></a>
				</noscript>
			</div>

			</div> 		 
	 
	
			 					</div>
				</div>
				<!-- end leaderboard ad -->
					</div>
		
		<span class="cleardiv"><!-- --></span>
		
	<div class="login-nav">
						
							
						
																	<div class="logon">
					<p><a href="http://www.nature.com/foxtrot/svc/login" class="login" title="login to Nature.com">Login</a><a class="cart" href="http://www.nature.com/ecommerce/cart/list.action">Cart</a> 
					</p>
									</div>
											
														
					<a href="http://www.nature.com/jp/" class="journal-header" title="Journal of Perinatology homepage"><img src="journal_header_v3.jpg" alt="Journal of Perinatology homepage" style="display: block;" class="journal-header-image"></a>				
				
				<form class="search" action="http://www.nature.com/search/executeSearch?" method="get">
			<div>
				<label for="searchtext">Search</label>
									<input name="sp-q-1" value="JP" type="hidden">
								<input id="searchtext" name="sp-q" value="" maxlength="200" type="text">
												<input name="sp-c" value="25" type="hidden">
												<input name="sp-m" value="0" type="hidden">
												<input name="sp-s" value="" type="hidden">
																								
														<input name="sp-a" value="sp1001702d" type="hidden">
										<input name="sp-sfvl-field" value="subject|ujournal" type="hidden">
										<input name="sp-x-1" value="ujournal" type="hidden">
										<input name="sp-p-1" value="phrase" type="hidden">
										<input name="sp-p" value="all" type="hidden">
													<input name="submit" class="button" value="go" title="search now" type="submit"> 					
								<a href="http://www.nature.com/search/adv_search?sp-a=sp1001702d&amp;sp-x-1=ujournal&amp;sp-q-1=jp">Advanced&nbsp;search</a>
							</div>
		</form>
		
							<span class="cleardiv"><!-- --></span>
			</div>
</div>


				<div style="display: none;">
	<!-- end global links -->
</div>
<div id="breadcrumb"><div><a href="http://www.nature.com/jp/index.html">Journal home</a><span class="divider"> &gt; </span><a href="http://www.nature.com/jp/journal/v27/n5/index.html"> Archive</a><span class="divider"> &gt; </span><a href="http://www.nature.com/jp/journal/v27/n5/index.html#oa">Original Articles</a><span class="divider"> &gt; </span><span class="thisitem">Full text</span></div></div>
<!-- content and journal nav --><div id="content-journalnav"><!-- content --><div id="content"><h1 class="page-header">Original Article</h1>
<p id="cite"><i>Journal of Perinatology</i> (2007) <b>27,</b> 284–290. doi:10.1038/sj.jp.7211686; published online 8 March 2007</p>
	
<h2 id="atl">Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease</h2>
<p id="aug">R D&nbsp;Christensen<sup><a title="affiliated with 1" href="#aff1">1</a>,<a title="affiliated with 2" href="#aff2">2</a></sup>, E&nbsp;Henry<sup><a title="affiliated with 1" href="#aff1">1</a>,<a title="affiliated with 3" href="#aff3">3</a></sup>, S E&nbsp;Wiedmeier<sup><a title="affiliated with 1" href="#aff1">1</a>,<a title="affiliated with 4" href="#aff4">4</a>,<a title="affiliated with 5" href="#aff5">5</a></sup>, J&nbsp;Burnett<sup><a title="affiliated with 1" href="#aff1">1</a>,<a title="affiliated with 4" href="#aff4">4</a></sup> and D K&nbsp;Lambert<sup><a title="affiliated with 1" href="#aff1">1</a>,<a title="affiliated with 2" href="#aff2">2</a></sup></p><div id="affiliations-notes"><ol><li id="aff1"><sup>1</sup>Intermountain Healthcare, Salt Lake City, UT, USA</li><li id="aff2"><sup>2</sup>Neonatology, McKay-Dee Hospital Center, Ogden, UT, USA</li><li id="aff3"><sup>3</sup>The Institute for Healthcare Delivery Research, Salt Lake City, UT, USA</li><li id="aff4"><sup>4</sup>Neonatology, LDS Hospital, Salt Lake City, UT, USA</li><li id="aff5"><sup>5</sup>Primary Children's Medical Center and the University of Utah School of Medicine, Salt Lake City, UT, USA</li></ol><p class="caff">Correspondence: Dr RD Christensen, Intermountain Health Care, 4300 Harrison Blvd, Ogden, UT 84403, USA. E-mail: <a href="mailto:rdchris4@ihc.com">rdchris4@ihc.com</a></p><p class="prdates">Received 14&nbsp;November&nbsp;2006; Revised 14&nbsp;January&nbsp;2007; Accepted 1&nbsp;February&nbsp;2007; Published online 8&nbsp;March&nbsp;2007.
			</p></div>
<div id="abs"><a class="backtotop" href="#top">Top<span class="hidden"> of page</span></a><h3>Abstract</h3><div><h4 class="abs">Background:</h4>&nbsp;<p class="follows-h4">Prolonged use of parenteral nutrition (PN) in neonates can lead to parenteral nutrition-associated liver disease (PNALD), manifested by elevated direct bilirubin concentrations, and in some cases progressing to hepatic failure. When new potential means of preventing PNALD in the neonatal intensive care unit (NICU), such as Omegaven usage, are tested in clinical trials, the studies should enroll neonates at a very high risk of developing PNALD. However, it is not always clear, in the first days of life, which neonates are most likely to develop PNALD. Therefore, preparatory to devising studies of prophylaxis against PNALD, we conducted an evaluation of all NICU patients who received PN for <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">14 day, assessing their likelihood of developing PNALD.</p><div class="norm"><!-- . --></div></div><div><h4 class="abs">Methods:</h4>&nbsp;<p class="follows-h4">We performed an historic cohort analysis of all neonates in the Intermountain Healthcare system, receiving PN for 14 days or more during their stay, with dates of birth between 1 January, 2002 and 30 June, 2006.</p><div class="norm"><!-- . --></div></div><div><h4 class="abs">Results:</h4>&nbsp;<p class="follows-h4">During the 4½-year period, 9861 neonates were cared for in the Intermountain Healthcare NICUs. Of these, 9547 (96.8%) survived for at least 28 days, and of these 6543 (68.5%) received PN. Twenty-one percent (1366 patients) of those receiving PN, received it for <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">14 days. PNALD was ascertained in this group by a direct bilirubin <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">2.0&nbsp;mg/dl. Neonates receiving PN for 14–28 days had a 14% incidence of PNALD, those receiving PN for 29–56 days had a 43% incidence, those receiving PN for 57–100 days had a 72% incidence and those receiving PN for &gt;100 days had a 85% incidence. Groups of patients identifiable on the first day of life as having the highest risk of developing PNALD were birth weight &lt;500&nbsp;g (odds ratio (OR), 30.7), birth weight 500–749&nbsp;g (OR, 13.1), gastrochisis (OR, 20.3) and jejunal atresia (OR, 24.0). Among 357 patients who developed PNALD, the highest direct bilirubin concentrations correlated with the highest serum alkaline phosphatase and transaminase concentrations. Deaths after 28 days were much more common in those with the highest direct bilirubin and transaminase concentrations (<i>P</i>&lt;0.0001).</p><div class="norm"><!-- . --></div></div><div><h4 class="abs">Conclusions:</h4>&nbsp;<p class="follows-h4">In the first days of life, certain NICU patients can be identified as being at very high risk for developing PNALD. These are patients &lt;750&nbsp;g birth weight, those with gastrochisis and those with jejunal atresia. We speculate that these groups would be reasonable subjects for including in a PNALD prophylaxis trial, testing new preventative strategies such as Omegaven usage.</p><div class="norm"><!-- . --></div></div><div class="keyw-abbr"><h4 class="keywords">Keywords: </h4><p class="keywords">parenteral nutrition, neonate, liver disease, PNALD, cholestasis</p></div><div class="keyw-abbr"><h4 class="abbreviations">Abbreviations: </h4><p class="abbreviations">NICU, neonatal intensive care unit; PN, parenteral nutrition; PNALD, parenteral nutrition-associated liver disease.</p></div></div>
<!-- articlebody start --><div id="articlebody"><div id="Introduction"><a class="backtotop" href="#top">Top<span class="hidden"> of page</span></a><h3>Introduction</h3><p class="norm">Parenteral nutrition (PN) is an integral aspect of neonatal intensive care, and can be life saving for critically ill neonates who are unable to receive adequate nourishment enterally.<sup><!--bib1--><a href="#bib1">1</a>, <!--bib2--><a href="#bib2">2</a></sup> However, PN can lead to the untoward outcome of PN-associated liver disease (PNALD), particularly when it is administered for many weeks.<sup><!--bib3--><a href="#bib3">3</a>, <!--bib4--><a href="#bib4">4</a></sup></p><p class="norm">Reducing the incidence or severity of PNALD would be an advance in neonatal intensive care. However, to date, studies testing prophylactic strategies have not identified a consistently successful method, other than discontinuing the PN, which frequently is not a feasible option. Those studies included prophylactic administration of taurosusodeoxycholic acid,<sup><!--bib5--><a href="#bib5">5</a></sup> cholecystokinin-octapeptide,<sup><!--bib6--><a href="#bib6">6</a>, <!--bib7--><a href="#bib7">7</a></sup> taurine,<sup><!--bib8--><a href="#bib8">8</a></sup> phenobarbitol<sup><!--bib9--><a href="#bib9">9</a></sup> and removing copper and manganese from the PN.<sup><!--bib10--><a href="#bib10">10</a>, <!--bib11--><a href="#bib11">11</a></sup></p><p class="norm">One problem inherent in any prophylactic strategy in the NICU is accurately predicting which neonates are at highest risk for developing the adverse outcome, so that high-risk patients can be eligible for study while low-risk patients can be excluded. Indeed, in the first days of life, when a prophylactic treatment to prevent PNALD might be started, it is not clear how to identify the neonates receiving PN who are at highest risk of developing PNALD. One problem in devising risk-assessment tools for PNALD is that in any given NICU, PNALD is rare. Therefore, for a series of patients to be sufficiently large to devise a meaningful risk assessment, single institutions must report their incidence of PNALD over decades. However, changes over time, in PN constituents, concomitant medications, equipment and other aspects of NICU care, can confound the interpretation of long-term chronological reports.</p><p class="norm">We sought to assess the occurrence of PNALD in a contemporary group of neonates cared for within Intermountain Healthcare, a large healthcare delivery system in the western United States. We studied all neonates in this system with dates of birth from 1 January, 2002 through 30 June, 2006, who received at least 14 days of PN. We hypothesized that this information would help us focus new experimental strategies for preventing PNALD, such as Omegaven use,<sup><!--bib12--><a href="#bib12">12</a>, <!--bib13--><a href="#bib13">13</a>, <!--bib14--><a href="#bib14">14</a>, <!--bib15--><a href="#bib15">15</a>, <!--bib16--><a href="#bib16">16</a></sup> on patients at highest risk for developing PNALD.</p></div><div id="Methods"><a class="backtotop" href="#top">Top<span class="hidden"> of page</span></a><h3>Methods</h3><p class="norm">Data were collected as a deidentified limited data set from archived Intermountain Healthcare records. The information collected was limited to the information displayed in the tables and figures of this report. Data were obtained for patients admitted to the NICU at McKay-Dee Hospital (Ogden, UT, USA), LDS Hospital (Salt Lake City, UT, USA), Primary Children's Medical Center (Salt Lake City, UT, USA), and Utah Valley Regional Medical Center (Provo, UT, USA) with a date of birth from 1 January, 2002 through 30 June, 2006. We studied only patients who received 14 days or more of PN and who survived at least 28 days or were discharged home before 28 days. PN was defined as an amino acid containing, multivitamin containing, intravenous solution ordered on the Intermountain Healthcare 'Parenteral Nutrition Program' and prepared by the hospital pharmacy PN team.</p><p class="norm">The program used for data collection was a modified subsystem of 'clinical workstation'. 3<span class="scp">M</span> Company (Minneapolis, MN, USA) approved the structure and definitions of all data points for use within the program. Data were collected from the electronic medical record, case mix, pharmacy and laboratory systems. Trained and designated clinical personnel enter and access data. Medical records (paper charts) were reviewed for all patients who received PN for 14 days or more and subsequently died. Evidence of PNALD was sought from autopsy findings<sup><!--bib17--><a href="#bib17">17</a>, <!--bib18--><a href="#bib18">18</a></sup> and from death summaries. In each death of a patient where a direct bilirubin &gt;2.0&nbsp;mg/dl was found, we also determined whether the direct bilirubin was increasing or decreasing in the weeks immediately preceding death. The Intermountain Healthcare Institutional Review Board approved the study.</p><p class="norm">Descriptive statistics were calculated using Statit (Corvallis, OR, USA). A logistic regression model was developed in Statit to calculate ORs. It calculates maximum likelihood fitting of regression where the response is a binomial variable, using the logistic (logit) model. Parameter estimates are presented on the anti-logarithmic scale. Proportions were compared between groups using <i><img src="glyph_001.gif" style="border: 0px none; vertical-align: middle;" alt="chi"></i><sup>2</sup> tests with Yate's continuity correction or, when counts were small, Fisher's exact test. Two-tailed tests were used, and for all tests <i><img src="glyph_002.gif" style="border: 0px none; vertical-align: baseline;" alt="alpha"></i> was set at 0.05.</p></div><div id="Results"><a class="backtotop" href="#top">Top<span class="hidden"> of page</span></a><h3>Results</h3><p class="norm">Between 1 January, 2002 and 30 June, 2006, 9861 neonates were cared for in four Intermountain Healthcare NICUs. Of these, 9547 (96.8%) were alive 28 days after birth or were discharged home before that day. Of these 9547 'survivors', 6543 (68.5%) received PN. The number of days PN was administered to each of these patients is shown in <!--fig1--><a href="#fig1">Figure 1</a>. Seventy-nine percent of those receiving PN received it for 13 days or fewer; conversely, 21% (1366 patients) of those receiving PN received it for 14 days or more. These 1366 patients, shown in <!--fig1--><a href="#fig1">Figure 1b</a>, are the basis of this report. These patients generally received intravenous lipid preparation up to 3&nbsp;g/kg/day as part of the PN. One hundred and forty-seven patients (2.2 %) received PN for 50 days or more and 14 patients (0.2%) received PN for 100 days or more. One received PN for 179 days.</p><div id="fig1" class="figure-table"><h5 class="norm"><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686f1.html#figure-title">Figure 1.</a></h5><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686f1.html#figure-title"><img alt="Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author" class="thumb" src="7211686f1th.jpg"></a><p>Number of days PN was administered. (<b>a</b>) The number of days is shown for each of 6543 NICU patients received PN. (<b>b</b>) More details of the 1366 patients who received PN for 14 days or more. Only patients who survived at least 28 days are included.</p><a class="full" href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686f1.html#figure-title">Full figure and legend (168<abbr title="Kilobyte">K</abbr>)</a><div class="cleardiv"><!-- clearing div --></div></div><br class="clear"><p class="norm"><!--tbl1--><a href="#tbl1">Table 1</a> categorizes the 1366 patients who received PN for <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">14 days according to their birth weight and whether they had surgery or extracorporeal membrane oxygenation. The majority (75%, 1022/1366) of those who received PN for <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">14 days were neonates <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">750&nbsp;g who did not have surgery. However, the groups with the highest probability of receiving PN for &gt;28 days were neonates &lt;750&nbsp;g (66%; 111/167), those with necrotizing enterocolitis (NEC) who underwent surgery (75%; 9/12), those with omphalocoele (54%; 6/11), jejunal atresia (59%; 13/22) or treated with extracorporeal membrane oxygenation (67%; 20/30). The groups with the highest probability of receiving PN for over 8 weeks (56 days) were those with NEC treated with laparotory (33%; 3/9), those with jejunal atresia (32%; 7/22), preterm infants &lt;750&nbsp;g birth weightt (19%; 32/167) and those with gastrochisis (15%; 13/86). We found no effect of gender or race on likelihood of developing PNALD.</p><div id="tbl1" class="figure-table"><h5 class="norm"><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686t1.html#figure-title">Table 1 - Classification of 1366 NICU patients who received PN for 14 days or more.</a></h5><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686t1.html#figure-title"><img alt="Table 1 - Classification of 1366 NICU patients who received PN for 14 days or more - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author" class="thumb" src="table_thumb.gif"></a><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686t1.html#figure-title" class="full">Full table </a><div class="cleardiv"><!-- clearing div --></div></div><br class="clear"><p class="norm">The great majority (93%) of the neonates who received PN for <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">14 days had multiple direct bilirubin values recorded. Twenty-eight percent (357/1266) had one or more direct bilirubin measurements <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">2.0&nbsp;mg/dl. <!--tbl2--><a href="#tbl2">Table 2</a> shows the percentage of patients who developed a direct bilirubin <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">2.0&nbsp;mg/dl as related to the categories in <!--tbl1--><a href="#tbl1">Table 1</a>. As the number of days on PN increased, the incidence of a direct bilirubin <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">2.0&nbsp;mg/dl increased. When all patient groups were considered together, those who received PN for 14–28 days had a 14% incidence (125/894) of developing a high direct bilirubin, those receiving PN for 29–56 days had a 43% incidence (164/382), those receiving PN for 57–100 days had a 72% incidence (68/94) and those receiving PN for &gt;100 days had a 86% incidence (12/14). The duration of the direct hyperbilirubinemia (<!--fig2--><a href="#fig2">Figure 2</a>) ranged from fewer than 10 days to more than 440 days.</p><div id="fig2" class="figure-table"><h5 class="norm"><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686f2.html#figure-title">Figure 2.</a></h5><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686f2.html#figure-title"><img alt="Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author" class="thumb" src="7211686f2th.jpg"></a><p>Duration of the direct hyperbilirubinemia. The number of days is shown between the first detection of an elevated direct bilirubin (&gt;2.0&nbsp;mg/dl) and the decrease to &lt;1.0&nbsp;mg/dl. Included are NICU patients who were treated for &gt;14 days with PN and survived at least 28 days after birth.</p><a class="full" href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686f2.html#figure-title">Full figure and legend (66<abbr title="Kilobyte">K</abbr>)</a><div class="cleardiv"><!-- clearing div --></div></div><br class="clear"><div id="tbl2" class="figure-table"><h5 class="norm"><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686t2.html#figure-title">Table 2 - Percent of patients receiving PN for &gt;14 days who developed a direct bilirubin &gt;2.0&nbsp;mg/dl.</a></h5><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686t2.html#figure-title"><img alt="Table 2 - Percent of patients receiving PN for >14 days who developed a direct bilirubin >2.0[thinsp]mg//dl - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author" class="thumb" src="table_thumb.gif"></a><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686t2.html#figure-title" class="full">Full table </a><div class="cleardiv"><!-- clearing div --></div></div><br class="clear"><p class="norm">Outcomes of the 1366 neonates who received PN for <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">14 days and survived at least 28 days are shown in <!--tbl3--><a href="#tbl3">Table 3</a>. Patient groups with the highest direct bilirubin concentrations also had the highest alkaline phosphatase, the highest serum glutamic pyruvic transaminase and the highest serum glutamic oxaloacetic transaminase values recorded. Patients who received PN for <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">14 days but whose direct bilirubin never exceeded 0.9&nbsp;mg/dl had a mortality rate of 3%. However, those whose direct bilirubin was <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">1.0&nbsp;mg/dl had a 9% mortality rate (<i>P</i>&lt;0.00001). Those with a direct bilirubin <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">11&nbsp;mg/dl had a 26% mortality rate (<i>P</i>&lt;0.00001 vs those with a bilirubin &lt;11&nbsp;mg/dl).</p><div id="tbl3" class="figure-table"><h5 class="norm"><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686t3.html#figure-title">Table 3 - Survival rates of NICU patients who received PN for <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">14 days, as related to their highest recorded direct bilirubin concentration.</a></h5><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686t3.html#figure-title"><img alt="Table 3 - Survival rates of NICU patients who received PN for [ges]14 days, as related to their highest recorded direct bilirubin concentration - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author" class="thumb" src="table_thumb.gif"></a><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686t3.html#figure-title" class="full">Full table </a><div class="cleardiv"><!-- clearing div --></div></div><br class="clear"><p class="norm">Seventy-one patients received PN for <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">14 days and subsequently died 28 days later. We sought to determine whether any of these 71 had PNALD, and if so whether it was improving or progressing (worsening) immediately before their death. Thirty patients who died had no evidence of PNALD, as they had no direct bilirubin measurement in excess of 2.0&nbsp;mg/dl (<!--tbl3--><a href="#tbl3">Table 3</a>). The remaining 41 all had a direct bilirubin exceeding 2.0&nbsp;mg/dl. None of these 41 had PNALD listed as the sole cause of death in the autopsy report or death summary. However, 32 of the 41 (73%) had PNALD identified as an active, progressing problem at the time of death.</p><p class="norm">Estimates of the odds of developing PNALD, depending on birth weight and surgical condition, are shown in <!--tbl4--><a href="#tbl4">Table 4</a>. The highest odds occurred among those weighing &lt;750&nbsp;g at birth, those who developed NEC and subsequently received surgery (either laparotomy or drain) and those with gastrochisis or jejunal atresia. When examined from the standpoint of which groups of patients, identifiable on the first day of life, were most likely to develop PNALD if they survived for &gt;28 days, the following risks were calculated: (1) patients weighting &lt;750&nbsp;g birth weight had a 39% likelihood of developing PNALD, (2) patients with gastrochisis had a 43% likelihood of developing PNALD and (3) patients with jejunal atresia had a 64% likelihood of developing PNALD.</p><div id="tbl4" class="figure-table"><h5 class="norm"><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686t4.html#figure-title">Table 4 - Logistic regression analysis, deriving odds ratios for developing PNALD, using the birth weight categories and surgical conditions as independent variables.</a></h5><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686t4.html#figure-title"><img alt="Table 4 - Logistic regression analysis, deriving odds ratios for developing PNALD, using the birth weight categories and surgical conditions as independent variables - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author" class="thumb" src="table_thumb.gif"></a><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686t4.html#figure-title" class="full">Full table </a><div class="cleardiv"><!-- clearing div --></div></div><br class="clear"></div><div id="Discussion"><a class="backtotop" href="#top">Top<span class="hidden"> of page</span></a><h3>Discussion</h3><p class="norm">When a neonate receives PN for many weeks, PNALD commonly develops. Kobuta <i>et al.</i><sup><!--bib19--><a href="#bib19">19</a></sup> reported that, in their experience all neonates receiving PN for over 8 weeks develop PNALD; defining PNALD as a direct bilirubin <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">2.0&nbsp;mg/dl. In the present study we observed a slightly lower incidence, of 76%, among 108 neonates who received PN for 8 weeks or more.</p><p class="norm">PNALD can be a lethal complication. Wales <i>et al.</i><sup><!--bib20--><a href="#bib20">20</a></sup> reported that PNALD has a disease-associated mortality rate of 3–13%. Various other reports indicate that the mortality rate of neonates with PNALD approaches 100%, if they are unable to be weaned off PN or if they fail to receive a liver/small bowel transplant.<sup><!--bib17--><a href="#bib17">17</a>, <!--bib18--><a href="#bib18">18</a></sup> We observed that among 71 neonates who received PN for <img src="glyph.gif" style="border: 0px none; vertical-align: middle;" alt="greater than or equal to">14 days and subsequently had a late (&gt;28 days) death PNALD was generally a problem and remained so at the time of death. However, it is not clear to what extent the PNALD actually contributed to the mortality. Certainly, the incidence of late death was higher among those with the highest direct bilirubin concentrations.</p><p class="norm">It has been postulated that PNALD is due, at least in part, to the lipid portion of PN, and that a lipid product high in omega-3 fatty acids produced from fish oil rather than soybean oil would lead to a lower incidence.<sup><!--bib14--><a href="#bib14">14</a>, <!--bib15--><a href="#bib15">15</a>, <!--bib21--><a href="#bib21">21</a></sup> One such product, Omegaven (Fresenius Kabi AG, Bad Homburg, Germany), has been administered to two neonatal patients with PNALD, in a recent report, with excellent success in reversing the process.<sup><!--bib14--><a href="#bib14">14</a></sup> Gura <i>et al.</i><sup><!--bib14--><a href="#bib14">14</a></sup> in reporting this encouraging experience called for randomized controlled trials testing lipid preparations that are high in omega-3 vs standard lipid preparations, as a means of preventing PNALD. We agree with this suggestion, adding that some of these prevention trials should focus on NICU patients who are at a very high risk of developing PNALD. In this way, neonates eligible for the study would be those with the most to gain from participating, whereas those with the least to gain would be excluded and therefore not be exposed to any potentially harmful effects of the test preparation.</p><p class="norm">It is challenging to predict, on the first day of life, which NICU patients will go on to develop PNALD. Nevertheless, attempting to identify these high-risk patients prospectively would be very useful. Our present data suggest that groups at highest risk are those born weighing &lt;750&nbsp;g and those with gastrochisis or jejunal atresia. Certainly, neonates with a variety of surgical conditions including midgut volvulus are at risk for developing PNALD, but perhaps not quite at as high a risk as those in the three groups mentioned.</p><p class="norm">Certain neonatal patients, not identifiable on the first day of life might also be good candidates for studying fish oil-based intravenous emulsions later during their hospital course. These groups would include patients who develop surgical NEC and are left with short remnant bowel length, because their odds of developing PNALD are very high.<sup><!--bib20--><a href="#bib20">20</a></sup> On the basis of the findings of the present study, we suggest that randomized trials to evaluate Omegaven or other potential means of preventing PNALD, where enrollment is to begin in the first days of life, should seek to enroll patients &lt;750&nbsp;g birth weight, or with gastrochisis or jejunal atresia. It appears that these groups are the most likely identifiable on the first day of life, to go on to develop PNALD. Therefore these patients are likely to accrue the benefits of successful PNALD prevention trials.</p></div><div id="References"><a class="backtotop" href="#top">Top<span class="hidden"> of page</span></a><h3>References</h3>
	<ol class="norm"><li id="bib1"><a name="bib1"><!-- . --></a>Thureen PJ, Hay Jr WW. Early aggressive nutrition in preterm infants. <span class="journal">Semin Neonatol</span> 2001; <span class="jnumber">6</span>: 403–415.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1053/siny.2001.0061" class="reftxt" title="">Article</a>&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=11988030&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:STN:280:DC%2BD383kvFGksg%3D%3D&amp;pissn=0743-8346&amp;pyear=2007&amp;md5=559207e1909b7aa8cdde92007ca40f1f" class="reftxt" title="Article on ChemPort - ">ChemPort</a>&nbsp;|</li><li id="bib2"><a name="bib2"><!-- . --></a>Ziegler EE, Thureen PJ, Carlson SJ. Aggressive nutrition of the very low birthweight infant. <span class="journal">Clin Perinatol</span> 2002; <span class="jnumber">29</span>: 225–244.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1016/S0095-5108(02)00007-6" class="reftxt" title="">Article</a>&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=12168239&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|</li><li id="bib3"><a name="bib3"><!-- . --></a>Teitlebaum DH. Parenteral nutrition-associated cholestasis. <span class="journal">Curr Opin Pediatr</span> 1997; <span class="jnumber">9</span>: 270–275.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1097/00008480-199706000-00016" class="reftxt" title="">Article</a>&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=9229168&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|</li><li id="bib4"><a name="bib4"><!-- . --></a>Kelly DA. Intestinal failure-associated liver disease: what do we know today? <span class="journal">Gastroenterology</span> 2006; <span class="jnumber">130</span>(2 Suppl 1): S70–S77.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1053/j.gastro.2005.10.066" class="reftxt" title="">Article</a>&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=16473076&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD28Xit12iu78%3D&amp;pissn=0743-8346&amp;pyear=2007&amp;md5=28bf2c8e95991c04e1ea234c0226bea9" class="reftxt" title="Article on ChemPort - ">ChemPort</a>&nbsp;|</li><li id="bib5"><a name="bib5"><!-- . --></a>Heubi JE, Wiechmann DA, Creutzinger V, Setchell KD, Squires Jr R, Couser R <i>et al</i>. Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease. <span class="journal">J Pediatr</span> 2002; <span class="jnumber">141</span>: 237–242.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1067/mpd.2002.125802" class="reftxt" title="">Article</a>&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=12183720&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD38Xnt1arsL0%3D&amp;pissn=0743-8346&amp;pyear=2007&amp;md5=f155b871e227e33d73bab12a3b33d452" class="reftxt" title="Article on ChemPort - ">ChemPort</a>&nbsp;|</li><li id="bib6"><a name="bib6"><!-- . --></a>Teitelbaum DH, Tracy Jr TF, Aouthmany MM, Llanso A, Brown MB, Yu S <i>et al</i>. Use of cholecystokinin–octapeptide for the prevention of parenteral nutrition-associated cholestasis. <span class="journal">Pediatrics</span> 2005; <span class="jnumber">115</span>: 1332–1340.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1542/peds.2004-1014" class="reftxt" title="">Article</a>&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=15867044&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|</li><li id="bib7"><a name="bib7"><!-- . --></a>Tietelbaum DH, Han-Markey T, Drongowski RA, Coran AG, Bayar G, Geiger JD <i>et al</i>. Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis. <span class="journal">JPEN J Parenter Enteral Nutr</span> 1997; <span class="jnumber">21</span>: 100–103.&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=9084013&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|</li><li id="bib8"><a name="bib8"><!-- . --></a>Spencer AU, Yu S, Tracy TF, Aouthmany MM, Llanos A, Brown MB <i>et al</i>. Parenteral nutrition-associated cholestasis in neonates: multivariate analysis of the potential protective effect of taurine. <span class="journal">JPEN J Parenter Enteral Nutr</span> 2005; <span class="jnumber">29</span>: 337–343.&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=16107596&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD2MXhtVemt7%2FK&amp;pissn=0743-8346&amp;pyear=2007&amp;md5=f535c4eb01ccc2db03f3157d73909c33" class="reftxt" title="Article on ChemPort - ">ChemPort</a>&nbsp;|</li><li id="bib9"><a name="bib9"><!-- . --></a>Gleghorn EE, Merritt RJ, Subramanian N, Ramos A. Phenobarbital does not prevent total parenteral nutrition-associated cholestasis in noninfected neonates. <span class="journal">JPEN J Parenter Enteral Nutr</span> 1986; <span class="jnumber">10</span>: 282–283.&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=3086586&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:STN:280:BimB38jpslI%3D&amp;pissn=0743-8346&amp;pyear=2007&amp;md5=e9bf9cbd5ea4741c1e89f2fe55e3fdfc" class="reftxt" title="Article on ChemPort - ">ChemPort</a>&nbsp;|</li><li id="bib10"><a name="bib10"><!-- . --></a>Blaszyk K, Wild PJ, Olivera A, Kelly DG, Burgart LJ. Hepatic copper in patients receiving long-term total parenteral nutrition. <span class="journal">J Clin Gastroenterol</span> 2005; <span class="jnumber">39</span>: 318–320.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1097/01.mcg.0000155135.35315.05" class="reftxt" title="">Article</a>&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=15758626&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|</li><li id="bib11"><a name="bib11"><!-- . --></a>Yip YY, Lim AK, Tan KL. A multivariate analysis of factors predictive of parenteral nutrition-related cholestasis (TPN cholestasis) in VLBW infants. <span class="journal">J Singapore Paediatr Soc</span> 1990; <span class="jnumber">32</span>: 144–148.&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=2133752&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:STN:280:By2C28jmsFA%3D&amp;pissn=0743-8346&amp;pyear=2007&amp;md5=c47d9bba7bd0207663bcd65d85999ac6" class="reftxt" title="Article on ChemPort - ">ChemPort</a>&nbsp;|</li><li id="bib12"><a name="bib12"><!-- . --></a>Van Aerde JE, Duerksen DR, Gramlich L, Meddings JB, Chan G, Thomson AB <i>et al</i>. Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets. <span class="journal">Pediatr Res</span> 1999; <span class="jnumber">45</span>: 202–208.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1203/00006450-199902000-00008" class="reftxt" title="">Article</a>&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=10022591&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DyaK1MXhtlKks7k%3D&amp;pissn=0743-8346&amp;pyear=2007&amp;md5=15faf4f6fd7c524d72495641c0941bc2" class="reftxt" title="Article on ChemPort - ">ChemPort</a>&nbsp;|</li><li id="bib13"><a name="bib13"><!-- . --></a>Alwayn IP, Gura K, Nose V, Zausche B, Javid P, Garza J <i>et al</i>. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. <span class="journal">Pediatr Res</span> 2005; <span class="jnumber">57</span>: 445–452.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1203/01.PDR.0000153672.43030.75" class="reftxt" title="">Article</a>&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=15659701&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD2MXhtl2mt7k%3D&amp;pissn=0743-8346&amp;pyear=2007&amp;md5=34ff9c2589a07bf1b9d66d459ed34529" class="reftxt" title="Article on ChemPort - ">ChemPort</a>&nbsp;|</li><li id="bib14"><a name="bib14"><!-- . --></a>Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR <i>et al</i>. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. <span class="journal">Pediatrics</span> 2006; <span class="jnumber">118</span>: e197–e201.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1542/peds.2005-2662" class="reftxt" title="">Article</a>&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=16818533&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|</li><li id="bib15"><a name="bib15"><!-- . --></a>Gura KM, Parsons SK, Bechard LJ, Henderson T, Dorsey M <i>et al</i>. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. <span class="journal">Clin Nutr</span> 2005; <span class="jnumber">24</span>: 839–847.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1016/j.clnu.2005.05.020" class="reftxt" title="">Article</a>&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=16029913&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD2MXhtVarsLjK&amp;pissn=0743-8346&amp;pyear=2007&amp;md5=7c4fd005aa39ef01c0b7cf9edeb9ccb4" class="reftxt" title="Article on ChemPort - ">ChemPort</a>&nbsp;|</li><li id="bib16"><a name="bib16"><!-- . --></a>Marcus AD. A doctor's push for drug pits him against its maker. <span class="journal">T Wall Street J</span> 2006; <span class="jnumber">248</span>: 1–15.</li><li id="bib17"><a name="bib17"><!-- . --></a>Mullick FG, Moran CA, Ishak KG. Total parenteral nutrition: a histopathologic analysis of the liver changes in 20 children. <span class="journal">Mod Pathol</span> 1994; <span class="jnumber">7</span>: 190–194.&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=8008742&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:STN:280:ByuB2sjpslE%3D&amp;pissn=0743-8346&amp;pyear=2007&amp;md5=e405194a983e8b015a3801270dc64b6e" class="reftxt" title="Article on ChemPort - ">ChemPort</a>&nbsp;|</li><li id="bib18"><a name="bib18"><!-- . --></a>Zambrano E, El-Hennawy M, Ehrenkranz RA, Zelterman D, Reyes-Mugica M. Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases. <span class="journal">Pediatr Dev Pathol</span> 2004; <span class="jnumber">5</span>: 425–432.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1007/s10024-001-0154-7" class="reftxt" title="">Article</a>&nbsp;|</li><li id="bib19"><a name="bib19"><!-- . --></a>Kobuta A, Yonekura T, Oyanagi H, Kawahara H, Yagi M <i>et al</i>. Total parenteral nutrition-associated intrahepatic cholestasis in infants: 25 years' experience. <span class="journal">J Pediatr Surg</span> 2000; <span class="jnumber">35</span>: 1049–1051.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1053/jpsu.2000.7769" class="reftxt" title="">Article</a>&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=10917294&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|</li><li id="bib20"><a name="bib20"><!-- . --></a>Wales PW, de Sliva N, Kim JH, Lecce I, Sandhu A, Moore AM. Neonatal short bowel syndrome: a cohort study. <span class="journal">J Pediatr Surg</span> 2005; <span class="jnumber">40</span>: 755–762.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1016/j.jpedsurg.2005.01.037" class="reftxt" title="">Article</a>&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=15937809&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|</li><li id="bib21"><a name="bib21"><!-- . --></a>Weinberger B, Watorek K, Strauss R, Witz G, Hiatt M, Hegyi T. Association of lipid peroxidation with hepatocellular injury in preterm infants. <span class="journal">Crit Care</span> 2002; <span class="jnumber">6</span>: 521–525.&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1186/cc1547" class="reftxt" title="">Article</a>&nbsp;|&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=12493074&amp;dopt=Abstract" class="reftxt" title="Article on PubMed - ">PubMed</a>&nbsp;|</li></ol></div><div id="more">
	<!-- generated by AJ standard table template --><div id="more"> <div id="more">  <a href="#top" class="backtotop">Top <span class="hidden">of page</span></a>   <h3>MORE ARTICLES LIKE THIS</h3>   <div class="box">    <p class="intro">These links to content published by NPG are automatically generated</p><div class="container"><h4 class="area">RESEARCH</h4><p class="title"><a href="http://www.nature.com/doifinder/10.1038/sj.jp.7211686">Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease</a></p><p class="source"><span class="journal">Journal of Perinatology</span> Original Article</p><p class="title"><a href="http://www.nature.com/doifinder/10.1038/sj.jp.7211738">Necrotizing enterocolitis in term neonates: data from a multihospital health-care system</a></p><p class="source"><span class="journal">Journal of Perinatology</span> Original Article</p><p class="title"><a href="http://www.nature.com/doifinder/10.1038/sj.jp.7211180">Severe Thrombocytopenia Predicts Outcome in Neonates with Necrotizing Enterocolitis</a></p><p class="source"><span class="journal">Journal of Perinatology</span> Original Article</p><p class="title"><a href="http://www.nature.com/doifinder/10.1038/sj.jp.7211603">Low blood neutrophil concentrations among extremely low birth weight neonates: data from a multihospital health-care system</a></p><p class="source"><span class="journal">Journal of Perinatology</span> Original Article</p><p class="seeall"><a href="http://sherlock.nature.com/arls/Query?src_jrnl=Journal%20of%20Perinatology&amp;src_vol=27&amp;query=http://xml.nature.com/jp/journal/v27/n5/xml/7211686a.xml&amp;type=oa&amp;src_pp=284-290&amp;prod=JP&amp;src_date=2007&amp;src_title=Identifying%20patients,%20on%20the%20first%20day%20of%20life,%20at%20high-risk%20of%20developing%20parenteral%20nutrition-associated%20liver%20disease&amp;showall=research" target="_new">See all 15 matches for Research</a></p></div></div></div></div></div></div><!-- articlebody end --></div><!-- end content --><div class="archive" id="journalnav"><h1 class="hidden">Main navigation</h1><!-- necessary for correct descending order heading hierarchy - do not remove! -->
	<!-- whitespace removed to deal with IE5.0 PC bug. -->
<map title="main journal navigation" id="main-journal-nav" class="journal-nav">
<ul><li class="jn-home"><a href="http://www.nature.com/jp/">Journal home</a></li>
	<li class="jn-aop"><a href="http://www.nature.com/jp/journal/vaop/ncurrent/">Advance online publication</a>
	<ul class="subnav"><li class="jn-about-aop"><a href="http://www.nature.com/jp/about_aop.html">About AOP</a></li></ul></li>
	<li class="jn-issue"><a href="http://www.nature.com/jp/journal/v36/n7/">Current issue</a></li>
	<li class="jn-archive"><a href="http://www.nature.com/jp/archive/index.html">Archive</a></li>
	<li class="jn-press-releases"><a href="http://www.nature.com/jp/press_releases.html">Press releases</a></li>
	<li class="jn-conferences"><a href="http://www.nature.com/jp/conferences.html">Conferences</a></li>
</ul>
</map>
	<!-- whitespace removed to deal with IE5.0 PC bug. -->
<map title="supplementary journal navigation" id="supplementary-journal-nav" class="journal-nav supplementary">
	<ul>
		<li class="jn-online-submission"><a href="http://www.mts-jper.nature.com/" class="submission">Online submission</a></li>
		<li class="jn-for-authors"><a href="http://www.nature.com/jp/for_authors.html">For authors</a></li>
		<li class="jn-for-referees"><a href="http://www.nature.com/jp/for_referees.html">For referees</a></li>
		<li class="jn-contact-eds"><a href="http://www.nature.com/jp/contact_eds.html">Contact editorial office</a></li>
		<li class="jn-about-the-journal"><a href="http://www.nature.com/jp/about.html">About the journal</a></li>
		<!--<li class="jn-about-the-society"><a href="/jp/about_society.html">About the society</a></li>-->
		<li class="jn-for-librarians"><a href="http://www.nature.com/jp/journal/v27/n5/full/advertising_us_full_addr.fhtml">For librarians</a></li>
		<li class="jn-subscribe"><a href="http://www.nature.com/jp/subscribe.html">Subscribe</a></li>
		<li class="jn-advertising"><a href="http://www.nature.com/jp/advertising.html">Advertising</a></li>
		<li class="jn-naturereprints"><a href="http://www.nature.com/reprints/">Reprints and permissions</a></li>
		<li class="jn-contact-npg"><a href="http://www.nature.com/jp/contact_npg.html">Contact NPG</a></li>
		<li class="jn-customer-services"><a href="http://mse.force.com/nature">Customer services</a></li>
		<li class="jn-site-features"><a href="http://www.nature.com/jp/site_features.html">Site features</a></li>
	</ul>
</map>
	
	
	<h2 class="npg-resources"><abbr title="Nature Publishing Group">NPG</abbr> resources</h2>
		<ul class="npg-resources">
			<li><a href="http://www.nature.com/ejhg/">European Journal of Human Genetics</a></li>
			<li><a href="http://www.nature.com/nm/">Nature Medicine</a></li>
			<li><a href="http://www.nature.com/npp/">Neuropsycho­pharmacology</a></li>
			<li><a href="http://www.nature.com/bmt/">Bone Marrow Transplantation</a></li>
		</ul>
	 
<div id="global-subject-areas">
	<h2><span><abbr title="Nature Publishing Group">NPG</abbr> Journals</span></h2>	
	<h3 class="view">by Subject Area</h3>
		<ul class="category-list">
		<li><h4>Chemistry</h4>
            <ul>
                <li><a href="http://www.nature.com/chemistry/index.html">Chemistry</a></li>
                <li><a href="http://www.nature.com/drugdisc/index.html">Drug discovery</a></li>
		<li><a href="http://www.nature.com/biotech/index.html">Biotechnology</a></li>
		<li><a href="http://www.nature.com/materials/index.html">Materials</a></li>
		<li><a href="http://www.nature.com/protometh/index.html">Methods &amp; Protocols</a></li>
            </ul>
        </li>        <li><h4>Clinical Practice &amp; Research</h4>
            <ul>
                <li><a href="http://www.nature.com/cancer/index.html">Cancer</a></li>
                <li><a href="http://www.nature.com/cardio/index.html">Cardiovascular medicine</a></li>
                <li><a href="http://www.nature.com/endocrinology/index.html" title="">Endocrinology</a></li>
                <li><a href="http://www.nature.com/gastrohep/index.html">Gastroenterology &amp; Hepatology</a></li>
		<li><a href="http://www.nature.com/protometh/index.html">Methods &amp; Protocols</a></li>
                <li><a href="http://www.nature.com/pathology/index.html">Pathology &amp; Pathobiology</a></li>
                <li><a href="http://www.nature.com/urology/index.html">Urology</a></li>

            </ul>
        </li>        <li><h4>Earth &amp; Environment</h4>
            <ul>
                <li><a href="http://www.nature.com/earthsciences/index.html">Earth sciences</a></li>
                <li><a href="http://www.nature.com/evoeco/index.html">Evolution &amp; Ecology</a></li>
	
            </ul>
        </li>        <li><h4>Life sciences</h4>
            <ul>
		<li><a href="http://www.nature.com/biotech/index.html">Biotechnology</a></li>
                <li><a href="http://www.nature.com/cancer/index.html">Cancer</a></li>
                <li><a href="http://www.nature.com/development/index.html">Development</a></li>
                <li><a href="http://www.nature.com/drugdisc/index.html">Drug discovery</a></li>
                <li><a href="http://www.nature.com/evoeco/index.html">Evolution &amp; Ecology</a></li>
                <li><a href="http://www.nature.com/genetics/index.html">Genetics</a></li>
                <li><a href="http://www.nature.com/immuno/index.html">Immunology</a></li>
                <li><a href="http://www.nature.com/medicalresearch/index.html">Medical research</a></li>
				<li><a href="http://www.nature.com/protometh/index.html">Methods &amp; Protocols</a></li>
                <li><a href="http://www.nature.com/micro/index.html">Microbiology</a></li>
                <li><a href="http://www.nature.com/molcellbio/index.html">Molecular cell biology</a></li>
                <li><a href="http://www.nature.com/neurosci/index.html">Neuroscience</a></li>
                <li><a href="http://www.nature.com/pharma/index.html">Pharmacology</a></li>
                <li><a href="http://www.nature.com/sysbio/index.html">Systems biology</a></li>
            </ul>
        </li>        <li><h4>Physical sciences</h4>
            <ul>
				<li><a href="http://www.nature.com/physics/index.html">Physics</a></li>
				<li><a href="http://www.nature.com/materials/index.html">Materials</a></li>
            </ul>
        </li>	</ul>
	
	<h3 class="view"><a href="http://www.nature.com/siteindex/index.html" title="View A to Z list of Nature Publishing Group journals">by A - Z Index</a></h3>
</div></div></div><!-- end content and journal nav --><div id="extranav"><h1 class="hidden">Extra navigation</h1><span class="page-header-spacer">.</span><div id="articlenav"><h2><span class="hidden">ARTICLE NAVIGATION - </span>FULL TEXT</h2><div class="prevnext"><a title="previous article in this issue" class="prev" href="http://www.nature.com/jp/journal/v27/n5/full/7211688a.html">Previous</a><span class="divider"> | </span><a title="next article in this issue" class="next" href="http://www.nature.com/jp/journal/v27/n5/full/7211693a.html">Next</a></div><ul><li class="toc"><a class="toc" href="http://www.nature.com/jp/journal/v27/n5/index.html">Table of contents</a></li><li class="download-pdf"><a class="download-pdf" href="http://www.nature.com/jp/journal/v27/n5/pdf/7211686a.pdf">Download PDF</a></li><li class="sendtofriend"><a class="sendtofriend" href="http://www.nature.com/foxtrot/svc/mailform?file=/jp/journal/v27/n5/full/7211686a.html">Send to a friend</a></li>

		
	
	
		
		
			


	<li class="readcube"><a href="http://www.readcube.com/articles/10.1038/sj.jp.7211686" class="readcube">View interactive PDF in ReadCube</a></li>

<li class="permissions"><a class="permissions" href="https://s100.copyright.com/AppDispatchServlet?publisherName=NPG&amp;publication=Journal+of+Perinatology&amp;title=Identifying%20patients,%20on%20the%20first%20day%20of%20life,%20at%20high-risk%20of%20developing%20parenteral%20nutrition-associated%20liver%20disease&amp;author=R%20D%20Christensen,%20E%20Henry,%20S%20E%20Wiedmeier,%20J%20Burnett%20and%20D%20K%20Lambert&amp;contentID=10.1038/sj.jp.7211686&amp;publicationDate=03/08/2007&amp;volumeNum=27&amp;issueNum=5">Rights and permissions</a></li><li class="commercial_reprints"><a class="commercial_reprints" href="https://s100.copyright.com/AppDispatchServlet?publisherName=NPGR&amp;publication=Journal+of+Perinatology&amp;title=Identifying%20patients,%20on%20the%20first%20day%20of%20life,%20at%20high-risk%20of%20developing%20parenteral%20nutrition-associated%20liver%20disease&amp;author=R%20D%20Christensen,%20E%20Henry,%20S%20E%20Wiedmeier,%20J%20Burnett%20and%20D%20K%20Lambert&amp;contentID=10.1038/sj.jp.7211686&amp;publicationDate=03/08/2007&amp;volumeNum=27&amp;issueNum=5&amp;numPages=7&amp;pageNumbers=pp284-290&amp;orderBeanReset=true">Order Commercial Reprints</a></li>
	<li class="cited"><a class="cited" href="http://www.nature.com/cited/cited.html?doi=10.1038/sj.jp.7211686">CrossRef lists 46 article
		s citing this article</a></li>
	<li class="cited"><a class="cited" href="http://www.scopus.com/inward/record.url?eid=&amp;partnerID=65">Scopus lists 89 articles citing this article</a></li><li class="save last"><a href="http://www.connotea.org/add?uri=http://www.nature.com/jp/journal/v27/n5/full/7211686a.html" class="save">Save this link</a></li><li><a class="page" href="#abs">Abstract</a></li><li><a class="page" href="#Introduction">Introduction</a></li><li><a class="page" href="#Methods">Methods</a></li><li><a class="page" href="#Results">Results</a></li><li><a class="page" href="#Discussion">Discussion</a></li><li><a class="page" href="#References">References</a></li><li><a href="http://www.nature.com/jp/journal/v27/n5/fig_tab/7211686ft.html#figure-title">Figures and Tables</a></li></ul><ul class="supplementary"><li><a href="http://www.nature.com/jp/journal/v27/n5/ris/7211686a.ris">Export citation</a></li><li><a href="http://www.nature.com/jp/journal/v27/n5/ris/7211686arefs.ris">Export references</a></li></ul><ul class="supplementary"><li><a class="" href="http://sherlock.nature.com/arls/Query?prod=JP&amp;query=http%3A%2F%2Fxml.nature.com%2Fjp%2Fjournal%2Fv27%2Fn5%2Fxml%2F7211686a.xml&amp;type=oa&amp;src_title=Identifying+patients%2C+on+the+first+day+of+life%2C+at+high-risk+of+developing+parenteral+nutrition-associated+liver+disease&amp;src_jrnl=Journal+of+Perinatology&amp;src_vol=27&amp;src_pp=284-290&amp;src_date=2007&amp;target=popup">More articles like this</a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Christensen+R">Papers by Christensen</a></li></ul></div>
					
<div class="box nature-feed" id="natjob">
<h2 class="natjob"><a href="http://www.nature.com/naturejobs/"><span class="first">nature</span><span class="hidden"> </span><span class="second">jobs</span></a></h2>

	<ul class="natjob">

	<li><h3 class="first"><a href="http://www.nature.com/naturejobs/science/jobs/557045-faculty-positions-at-idg-mcgovern-institute-for-brain-research-at-peking-university">Faculty Positions at IDG / McGovern Institute for Brain Research at Peking University</a></h3>
	<ul>
	<li>IDG/McGovern Institute for Brain Research at Peking University</li>
		</ul>
	</li>

			<li><h3><a href="http://www.nature.com/naturejobs/science/jobs/571105-gastroenterologist">Gastroenterologist</a></h3>
		<ul>
		<li>Loyola University Chicago</li>
				</ul>
		</li>
	</ul>


<div class="natjobmore"><a href="http://www.nature.com/naturejobs/science/jobs">More science jobs</a></div>
<div class="natjobmore"><a href="http://www.nature.com/naturejobs/science/jobs/new">Post a job</a></div>
</div>


<div class="box nature-feed" id="natevents">
<h2 class="natjob"><a href="http://www.nature.com/nature-events/index.html"><span class="first">nature</span><span class="hidden"> </span><span class="second">events</span></a></h2>

<ul class="natjob">
	<li>
	  <h3 class="first"><a href="http://www.nature.com/natureevents/science/events/44961-Immune_Profiling_in_Health_and_Disease">Immune Profiling in Health and Disease</a></h3>
  	<ul>
    	<li>
					<strong>03 October 2016 — 05 October 2016</strong>
		    	</li>
    	<li>Seattle, WA, United States</li>
  	</ul>
	</li>
	<li>
	  <h3><a href="http://www.nature.com/natureevents/science/events/43105-The_Biology_of_Calpains_in_Health_Disease">The Biology of Calpains in Health &amp; Disease</a></h3>
  	<ul>
    	<li>
					<strong>17 July 2016 — 22 July 2016</strong>
		    	</li>
    	<li>Big Sky, MT, United States</li>
  	</ul>
	</li>
</ul>
<div class="natjobmore"><a href="http://www.nature.com/nature-events/index.html">More science events</a></div>
</div>


	
	<!-- skyscraper ad -->
<div class="ad-vert">

ADVERTISEMENT<br>


							<!-- Using GPT ads -->
																																																																																																																				
						
																																																		<div class="adunit-leaderboard"> 
							<!-- FLEXI -->
			
			
						
			
		
							
		
													
		
										
		
													
		
										
		
													
		
										
		
													
		
										
		
													
		
										
		
									
		
	
	
		
										
					
		
										
					
		
										
					
		
										
					
		
										
					
		
										
									<div id="div-gpt-ad-2" class="div-gpt-ad adunit-leaderboard" data-gpt-unitpath="/285/jp.nature.com" data-gpt-sizes="160x600" data-gpt-targeting="type=oa;artid=7211686a;issue=5;pos=right;sz=160x600;tile=2">
				<noscript>

					<a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/jp.nature.com&amp;sz=160x600&amp;t=type=oa;artid=7211686a;issue=5;pos=right;sz=160x600;tile=2&amp;c=1182815578939803">
						<img src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/jp.nature.com&amp;sz=160x600&amp;t=type=oa;artid=7211686a;issue=5;pos=right;sz=160x600;tile=2&amp;c=1182815578939803" alt="Advertisement" /></a>
				</noscript>
			</div>

			</div> 		 
	 
	
			 </div>
<!-- end skyscraper ad --></div>
	<!-- global links -->
	

	



<div class="cleardiv"><!-- --></div>


			
			<p class="back-to-top hidden"><a href="#top" title="Return to the top of this page">Top</a></p>
	
	<div id="ftr" class="footer">
					<div class="cope cope-bottom-align"><a href="http://publicationethics.org/" title="Committee on Publication Ethics - external website."><img src="logo_cope.gif" alt=""></a><br>This journal is a member of and subscribes to the principles of the <a href="http://publicationethics.org/" alt="">Committee on Publication Ethics</a>.</div>
			<span class="cleardiv"><!-- --></span>
							<ul id="footer-journal" class="narrow-journal-info">
				<li class="journal-name">Journal of Perinatology</li>				<li class="issn"><abbr title="International Standard Serial Number">ISSN</abbr><span class="hidden">:</span> 0743-8346</li>				<li class="eissn"><abbr title="Electronic International Standard Serial Number">EISSN</abbr><span class="hidden">:</span> 1476-5543</li>															</ul>
			<span class="cleardiv"><!-- --></span>
		
		<div class="footer-inner">

		<div class="baseline-wrapper">
													<ul class="footer-links baseline first">
									<li><a href="http://www.nature.com/npg/">About <abbr title="Nature Publishing Group">NPG</abbr></a></li>
														<li><a href="http://www.nature.com/npg_/contact/">Contact <abbr title="Nature Publishing Group">NPG</abbr></a></li>
														<li><a href="http://www.nature.com/info/accessibility_statement.html">Accessibility statement</a></li>
														<li><a href="http://www.nature.com/help/">Help</a></li>
													</ul>
							<ul class="footer-links baseline">
									<li><a href="http://www.nature.com/info/privacy.html">Privacy policy</a></li>
														<li><a href="http://www.nature.com/info/cookies.html">Use of cookies</a></li>
														<li><a href="http://www.nature.com/info/legal_notice.html">Legal notice</a></li>
														<li><a href="http://www.nature.com/info/tandc.html">Terms</a></li>
													</ul>
							<ul class="footer-links baseline last">
									<li><a href="http://www.nature.com/naturejobs/">Nature<span class="hidden"> </span>jobs</a></li>
														<li><a href="http://www.natureasia.com/">Nature Asia</a></li>
														<li><a href="http://www.nature.com/scitable/">Nature Education</a></li>
														<li><a href="http://www.nature.com/webfeeds/"><abbr title="RDF Site Summary">RSS</abbr> web feeds</a></li>
													</ul>
			
						<form style="height: 68px;" action="http://www.nature.com/search/executeSearch" method="get" class="search-form baseline">
				<fieldset>
					<label for="footer-search">Search:</label>
					<input id="footer-search" name="sp-q" value="" class="text" maxlength="200" type="text">
					<input name="sp-p" value="all" type="hidden">
					<input name="sp-c" value="25" type="hidden">
					<input name="sp-m" value="0" type="hidden">
											<input name="sp-s" value="date_descending" type="hidden">
															<input name="search" value="go" class="button" type="submit">
				</fieldset>
			</form>
					</div>

		<span class="cleardiv"><!-- --></span>

					<div id="footer-copyright">
				<ul class="logo">
											<li>
															<img alt="Springer Nature" class="logo-image" src="JrCvv3CPB3wrPu8Ho99jMDWQY9ryFlbCZA3GGszeeUKYrcCBITB0zj72rf6JKh8EY2Kx6vLF8kzOEXTncaE8i3fihXKmm3TsNrAJ" height="14" width="140">
														© 2016 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.
						</li>
										<li> partner of <a href="http://www.nature.com/info/partners.html">AGORA, HINARI, OARE, INASP, ORCID, CrossRef, COUNTER and COPE</a></li>				</ul>
			</div>
				</div>
	</div>

	</div></div><!-- close constrain divs -->

	<!-- end global links --><!-- super body bottom -->
<div id="div-gpt-ad-3" class="ad adunit-out-of-page div-gpt-ad out-of-page" data-gpt-unitpath="/285/jp.nature.com" data-gpt-targeting="type=oa;artid=7211686a;issue=5;pos=right;sz=160x600;tile=2"></div>
<!-- super javascript -->

	
																																			
																																														
										<script type="text/javascript" src="jquery.js"></script>
												<script type="text/javascript" src="cookie.js"></script>
												<script type="text/javascript" src="message.js"></script>
												<script type="text/javascript" src="ping"></script>
												<script type="text/javascript" src="baseline.jquery.js"></script>
												<script type="text/javascript" src="global.baseline.js"></script>
												<script type="text/javascript" src="tsedge_instr-min.js"></script>
						
	
	<script type="text/javascript"><!--//--><![CDATA[//><!--
	(function($) {
		$('a.popup-this').bind('click', function() {
			window.open(this.href);
			return false;
		});
	})(jQuery);
	//--><!]]></script>

	

																																																																																																																																																																																																																																								
<!--[if IE 6]>
	<script type="text/javascript" src="/aj/scripts/ie-specific/ie-6.js"></script>
<![endif]-->
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																
 

			<!-- Nielsen/NetRatings SiteCensus V5.3 -->
	<script type="text/javascript"><!--//--><![CDATA[//><!--
		var _rsCI="us-nature";
		var _rsCG="0";
		var _rsDN="//secure-us.imrworldwide.com/";
		var _rsPLfl=0;
		var _rsSE=1;
		var _rsSM=1.0;
		var _rsCL=1;
	//--><!]]></script>
	<script type="text/javascript" src="v53.js"></script><script language="JavaScript" type="text/javascript" src="j"></script><img src="m" alt="" height="1" width="1"> 	<noscript>

		<div><img src="http://secure-us.imrworldwide.com/cgi-bin/m?ci=us-nature&amp;cg=0&amp;cc=1" alt="" /></div>
	</noscript>





	<script type="text/javascript" src="global.webtrends.js"></script>
	<noscript>

		<div><img alt="" id="DCSIMG" width="1" height="1" src="//statse.webtrendslive.com/dcs0zztfg00000s969s37qoal_2f6z/njs.gif?dcsuri=/nojavascript&amp;WT.js=No&amp;WT.tv=10.2.55" /></div>
	</noscript>

<script src="chartbeat.js" type="text/javascript"></script><iframe id="kx-proxy-Jn7TaPwq" src="7211686a_1.html" style="display: none; visibility: hidden; height: 0px; width: 0px;"></iframe><div class="kxhead" data-id="Jn7TaPwq" style="display: none ! important;"></div></body>
</html>
